Sort by:

select Language:

Pandemic Preparedness and Response – Lessons from the H1N1 Influenza of 2009

Harvey V. Fineberg, (2014)

New England Journal of Medicine 2014; 370:1335-1342. Please download the pdf-file from the nejm Website! A number of viruses have pandemic potential. The most recent global pandemic was caused by the influenza A (H1N1) strain, which was first detected in North America in 2009. The 2009 H1N1 pandemic presented a public health emergency of uncertain scope, duration, and effect. At the request of the WHO, an international committee reviewed the experience of the pandemic, with special attention given to the function of the 2005 International Health Regulations (IHR) and the performance of the WHO. The most fundamental conclusion of the committee, which applies today, is not reassuring: “The world is ill prepared to respond to a severe influenza pandemic or to any similarly global, sustained and threatening public-health emergency

TB treatment in a chronic complex emergency: treatment outcomes and experiences in Somalia

Karin Fischer Liddlea, Riekje Elemaa, Sein Sein Thib, Jane Greigb,and Sarah Venisb, Eds.: MSF, (2013)

Trans R Soc Trop Med Hyg 2013; 1–9. Please download from the website as "guest"

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

John R. Perfect, William E. Dismukes, Francoise Dromer, et al., Eds.: Infectious Diseases Society of America, (2010)

Clinical Infectious Diseases 2010; 50:291–322

MDR-TB Weight-Based Dosing Chart for Children

Sentinel Project, (2013)

Therapy for MDR-TB is extremely long, complex and burdensome to both patients and health care systems. A single diagnosis can require two years of treatment, or longer. When treating children, there are significant additional barriers treating children with MDR-TB. There is limited data on the pharmacokinetics of second-line TB drugs in children, and almost none are in child-friendly formulations. Nonetheless, there is continued work on second-line drugs to fight MDR-TB. The Sentinel Project has created a complex set of dosing recommendations for administering second-line drugs to children

Management of tuberculosis and HIV coinfection

Robert Colebunders, Manfred Danilovits, Kayt Erdahl et al., Eds.: World Health Organization, (2013)

This publication is an updated version of the Management of Tuberculosis and HIV Coinfection clinical protocol released in 2007 by the WHO Regional Office for Europe. It is intended for all health care workers involved in preventing, diagnosing, treating and caring for people living with TB and HIV in the specific settings of the WHO European Region.

Guidelines for the Management of Tuberculosis, Human Immunodeficiency Virus and Sexually-Transmitted Infections in Correctional facilities 2013

Department of Health, Republic of South Africa, (2013)

The guidelines acknowledge that overcrowding, unhygienic conditions and high inmate turn over contribute to the spread of infectious diseases within correctional facilities. The document states that voluntary HIV counselling and testing must be offered to all inmates when they enter facilities, during their incarceration at an inmate’s request and upon their release. All inmates must be screened for TB symptoms upon entry to facilities and at least bi-annually thereafter as well as upon release. Universal screening for anal, oral and genital STIs must be done at entry and upon self-presentation

Dermatological Preparations For The Tropics

Peter Bakker; Herman Woerdenbag; Vincent Gooskens; Ben Naafs, et al., (2012)

A formulary of dermatological preparations and background information on therapeutic choices, production and dispensing. 2nd edition

338 hits